New SFDA Chief Aims For Greater Global Recognition Of Exports
This article was originally published in PharmAsia News
Executive Summary
China’s new State FDA Chief Yin Li said the 12th Five-Year Plan for drug safety is based on current international pharmaceutical standards, and he aims to increase international recognition of Chinese pharma exports.